Double-promoter plasmid as well as preparation method and application thereof

By designing a double promoter plasmid in Kluvier lactate, the galactosidase promoter induction mechanism was used to solve the problem of insufficient expression of heterologous proteins, achieving efficient protein expression, and significantly improving yield.

CN118995781APending Publication Date: 2024-11-22CUSABIO TECH LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411125638.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Kluvier lactic acid has the problem of low yield or no expression when heterologously expressing exogenous proteins.

Method used

Design a dual promoter plasmid to improve the protein expression process by connecting galactosidase promoter on pKLAC1 expression vector, using the lactose induction mechanism, promote the expression of difficult or non-expressed proteins, and construct it through DNA ligation and enzyme cleavage technology Recombinant expression vectors to achieve efficient expression in Kluvier lactic acid.

Benefits of technology

The yield of exogenous proteins in Kluvier lactate was significantly improved, such as the production of green fluorescent protein increased by about 5.5 times, solving the problem of insufficient protein expression.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995781A_ABST
    Figure CN118995781A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of molecular biology, in particular to a double-promoter plasmid as well as a preparation method and application thereof. The double-promoter plasmid comprises a pKLAC1 expression vector and a galactosidase promoter connected to the pKLAC1 expression vector in series, and a protein expressed by the galactosidase promoter has an amino acid sequence as shown in SEQ ID NO. 1. A galactosidase promoter is connected in series on a pKLAC1 expression vector to form a double-promoter plasmid, and when kluyveromyces lactis is on a culture medium taking lactose as a unique carbon source, the galactosidase promoter in the double-promoter plasmid can drive protein which is difficult to express or not to express on the pKLAC1 expression vector to express; in addition, the kluyveromyces lactis can generate a large amount of galactose in a lactose environment, so that the expression of a pKLAC1 expression vector is further promoted, and the yield of heterologous expression foreign protein of the kluyveromyces lactis is increased.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of molecular biotechnology, and in particular to a dual-promoter plasmid and a preparation method and application thereof. Background Art

[0002] Kluyveromyces lactis is an unconventional yeast first isolated from milk and is a strictly aerobic bacterium. Kluyveromyces lactis cells are spherical or elliptical, and mainly perform multilateral budding. They are a strain that can grow in a culture medium with lactose as the sole carbon source. In a culture medium with lactose as the sole carbon source, the enzymes related to the lactose metabolic pathway of Kluyveromyces lactis cells are strongly induced by lactose. Under the action of lactose permease (encoded by the LAC12 gene), they enter the Kluyveromyces lactis cells and metabolize them into galactose through β-galactoside (encoded by the LAC4 gene). In addition, the yeast can also decompose and utilize raffinose, maltose, xylose, xylitol, and some carbon sources that are not easily utilized by yeast, such as cellobiose, 2,3-butanediol, sorbose, etc., to obtain energy, and the culture components are simple. In addition, the Kluyveromyces lactis chassis cells are used as heterologous expression hosts, which have the advantages of food-safe microorganisms, easy genetic manipulation, strong protein secretion ability, moderate glycosylation, and no need for methyl-nutritional yeast; at the same time, Kluyveromyces lactis also has the ability to achieve large-scale production of pharmaceutical proteins in the pharmaceutical industry. At present, research has been able to achieve the successful expression of most pharmaceutical-related proteins in Kluyveromyces lactis, including mammalian protein interleukin 1-P, interferon α, β-lactoglobulin, lysozyme, and insulin precursors. In addition, at present, most enzyme preparations need to be separated from proteins after production before they can enter the food chain and other industries; and in view of the characteristics of secretory expression of organisms and the attributes of food safety, the use of Kluyveromyces lactis for protein production can greatly save the process from fermentation to finished products, thereby effectively saving time in production.

[0003] However, when heterologously expressing in Kluyveromyces lactis, some proteins may have relatively low yields or not be expressed. Summary of the invention

[0004] The present application provides a dual-promoter plasmid and a preparation method and application thereof to solve the following technical problem: how to increase the yield of foreign protein heterologously expressed in Kluyveromyces lactis.

[0005] In a first aspect, the present application provides a dual promoter plasmid, the dual promoter plasmid comprising:

[0006] pKLAC1 expression vector and a β-galactosidase promoter connected in series on the pKLAC1 expression vector, wherein the protein expressed by the β-galactosidase promoter has an amino acid sequence as shown in SEQ ID NO.1.

[0007] Optionally, the β-galactosidase promoter includes a spacer gene sequence, an α-factor signal peptide gene sequence, a functional region gene sequence and a connecting gene sequence; the spacer gene sequence is located upstream of the functional region gene sequence, the connecting gene sequence is located downstream of the functional region gene sequence, and the α-factor signal peptide gene sequence is located downstream of the connecting sequence.

[0008] Optionally, the spacer gene sequence has a nucleotide sequence as shown in SEQ ID NO.2;

[0009] The α factor signal peptide gene sequence has a nucleotide sequence as shown in SEQ ID NO.3;

[0010] The connecting gene has a nucleotide sequence as shown in SEQ ID NO.4.

[0011] Optionally, the β-galactosidase promoter has a nucleotide sequence as shown in SEQ ID NO.5.

[0012] In a second aspect, the present application provides a method for preparing the dual promoter plasmid described in the first aspect, the method comprising:

[0013] The plasmid containing the β-galactosidase promoter is subjected to a first double restriction enzyme digestion to obtain a promoter gene fragment;

[0014] Performing the first double enzyme digestion on the pKLAC1 expression vector to obtain a first vector enzyme digestion product;

[0015] The promoter gene fragment and the vector enzyme-cut product are connected by DNA to obtain a double-promoter plasmid.

[0016] Optionally, the enzymes used for the first double enzyme digestion include HindⅢ enzyme and BglⅡ enzyme.

[0017] In a third aspect, the present application provides a recombinant expression strain of Kluyveromyces lactis, wherein the recombinant expression strain has the dual promoter plasmid described in the first aspect.

[0018] In a fourth aspect, the present application provides a method for constructing a recombinant expression strain of Kluyveromyces lactis according to the third aspect, the method comprising:

[0019] Performing a second double enzyme digestion on the plasmid containing the foreign protein to obtain the foreign protein gene fragment;

[0020] Perform a second double enzyme digestion on the pKLAC1 vector to obtain a second vector digestion product;

[0021] Performing DNA ligation on the exogenous protein gene fragment and the second vector digestion product to obtain a recombinant expression vector;

[0022] Using the method described in the second aspect, the β-galactosidase promoter is transferred into the recombinant expression vector to obtain a dual-promoter recombinant expression vector containing the β-galactosidase promoter;

[0023] Cutting the dual-promoter recombinant expression vector with enzymes to linearize the dual-promoter recombinant expression vector, thereby obtaining a linearized dual-promoter recombinant expression vector;

[0024] The linearized dual-promoter recombinant expression vector is mixed with Kluyveromyces lactis competent cells, and then electro-transformed to obtain a recombinant expression single strain;

[0025] The recombinant expression single strain is induced and amplified using a culture medium with D-galactose as the sole carbon source to obtain a recombinant expression strain of Kluyveromyces lactis.

[0026] Optionally, the expression gene of the exogenous protein has a nucleotide sequence as shown in SEQ ID NO.6;

[0027] The exogenous protein has an amino acid sequence as shown in SEQ ID NO.7.

[0028] Optionally, the enzymes used for the second double enzyme digestion include AscⅠ enzyme and NotⅠ enzyme.

[0029] Optionally, the enzyme used for the enzyme cleavage includes SacII enzyme.

[0030] The above technical solution provided by the embodiment of the present application has the following advantages compared with the prior art:

[0031] A dual-promoter plasmid provided in an embodiment of the present application comprises: a pKLAC1 expression vector and a galactosidase promoter serially connected to the pKLAC1 expression vector, wherein the protein expressed by the galactosidase promoter has an amino acid sequence as shown in SEQ ID NO.1; based on the original promoter of the pKLAC1 expression vector, the galactosidase promoter is serially connected to the pKLAC1 expression vector to form a dual-promoter plasmid with dual promoters; when Kluyveromyces lactis is in a culture medium with lactose as the sole carbon source, the galactosidase promoter in the dual-promoter plasmid can effectively start the expression process of some proteins in Kluyveromyces lactis to drive the expression of proteins that are difficult to express or not expressed on the pKLAC1 expression vector; in addition, Kluyveromyces lactis will produce a large amount of galactose in a lactose environment, and a large amount of galactose can cooperate with the galactosidase promoter in the dual-promoter plasmid to further promote the expression of the pKLAC1 expression vector, so as to increase the yield of heterologous expression of exogenous proteins in Kluyveromyces lactis. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the present application and, together with the description, serve to explain the principles of the present application.

[0033] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0034] Figure 1 A schematic flow chart of a method for preparing a dual-promoter plasmid provided in an embodiment of the present application;

[0035] Figure 2 A schematic diagram of the principle of a method for preparing a dual-promoter plasmid provided in an embodiment of the present application;

[0036] Figure 3 A plasmid map of a recombinant expression strain of Kluyveromyces lactis provided in an embodiment of the present application;

[0037] Figure 4 A schematic diagram of a method for constructing a recombinant expression strain of Kluyveromyces lactis provided in an embodiment of the present application;

[0038] Figure 5 This is a diagram showing the detection results of the recombinant expression vector after single enzyme digestion and the dual promoter recombinant expression vector provided in the examples of the present application; wherein, Figure 5The middle lane M is Marke, and from top to bottom are 250bp, 1000bp, 2500bp, 5000bp, 7500bp, 10000bp and 15000bp; Lane 1 is the constructed recombinant expression vector pKLAC-EGFP, 9787bp; Lane 2 is the constructed dual promoter recombinant expression vector pKLAC1-pScGAL7-EGFP, 10909bp;

[0039] Figure 6 The detection result diagram of the recombinant expression vector pKLAC-EGFP and the dual promoter recombinant expression vector pKLAC1-pScGAL7-EGFP after four enzyme digestion provided in the examples of the present application; wherein, Figure 6 The middle lane M is Marke, and from top to bottom are 250bp, 1000bp, 2500bp, 5000bp, 7500bp, 10000bp and 15000bp; Lane 1 is the product of the constructed recombinant expression vector pKLAC-EGFP digested with HindⅢ enzyme, BglⅡ enzyme, AscⅠ enzyme and NotⅠ enzyme, 9787bp; Lane 2 is the product of the constructed dual-promoter recombinant expression vector pKLAC1-pScGAL7-EGFP digested with HindⅢ enzyme, BglⅡ enzyme, AscⅠ enzyme and NotⅠ enzyme, 10909bp;

[0040] Figure 7 Schematic diagram of the protein detection results expressed by the recombinant expression strain corresponding to the recombinant expression vector pKLAC-EGFP and the dual-promoter recombinant expression vector pKLAC1-pScGAL7-EGFP provided in the embodiments of the present application; wherein, Figure 7 The middle lane M is Marke, and from top to bottom are 14.4 kDa, 18.4 kDa, 25 kDa, 35 kDa, 45 kDa, 66.4 kDa and 116 kDa; Lane 1 is the supernatant obtained by fermentation after the constructed recombinant expression vector pKLAC-EGFP was transformed into lactic acid Kluyveromyces engineering bacteria; Lane 2 is the supernatant obtained by fermentation after the constructed dual-promoter recombinant expression vector pKLAC1-pScGAL7-EGFP was transformed into lactic acid Kluyveromyces engineering bacteria. DETAILED DESCRIPTION

[0041] In order to make the purpose, technical solution and advantages of the embodiments of the present application clearer, the technical solution in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of this application.

[0042] Various embodiments of the present application may be presented in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity and should not be understood as a rigid limitation on the scope of the present application; therefore, it should be considered that the range description has specifically disclosed all possible sub-ranges and single numerical values ​​within the range; for example, it should be considered that the range description from 1 to 6 has specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the range, such as 1, 2, 3, 4, 5 and 6, which applies regardless of the range; in addition, whenever a numerical range is indicated in this document, it is meant to include any cited numbers (fractions or integers) within the indicated range.

[0043] In this document, the terms including "including" and "including" mean "including but not limited to". Relational terms such as "first" and "second" are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. "And / or" describes the association relationship of associated objects, indicating that there can be three relationships. For example, A and / or B can mean: A exists alone, A and B exist at the same time, and B exists alone; where A and B can be singular or plural. "At least one" means one or more, and "plurality" means two or more; "at least one", "at least one of the following" or similar expressions refer to any combination of these items, including any combination of single or plural items; for example, "at least one of a, b, or c", or "at least one of a, b, and c" can all mean: a, b, c, ab (i.e., a and b), ac, bc, or abc, where a, b, and c can be single or multiple. Unless otherwise specified, various raw materials, reagents, instruments and equipment used in this application can be purchased from the market or prepared by existing methods.

[0044] It should be noted that the pScGAL7 promoter is a promoter in Saccharomyces cerevisiae, which belongs to the GAL (galactose-induced) promoter family. The GAL promoter is usually induced by galactose and can be inhibited by glucose; current studies have shown that the pScGAL7 promoter can also work in Kluyveromyces lactis, and can successfully initiate the expression of enhanced green fluorescent protein (EGFP), and compared with several other promoters, the expression ability of pScGAL7 is improved after adding galactose. Therefore, based on the important role of the pScGAL7 promoter in gene expression regulation, especially in the fields of metabolic engineering and synthetic biology, the pScGAL7 promoter can be used to produce valuable products.

[0045] The present application embodiment provides a dual promoter plasmid, and the dual promoter plasmid comprises:

[0046] pKLAC1 expression vector and a β-galactosidase promoter connected in series on the pKLAC1 expression vector, wherein the protein expressed by the β-galactosidase promoter has an amino acid sequence as shown in SEQ ID NO.1.

[0047] It should be noted that the β-galactosidase promoter may be a pScGAL7 promoter.

[0048] In some optional embodiments, the β-galactosidase promoter comprises a spacer gene sequence, an α-factor signal peptide gene sequence, a functional region gene sequence and a connecting gene sequence; the spacer gene sequence is located upstream of the functional region gene sequence, the connecting gene sequence is located downstream of the functional region gene sequence, and the α-factor signal peptide gene sequence is located downstream of the connecting sequence;

[0049] In these embodiments, the galactosidase promoter may include a spacer gene sequence, an α-factor signal peptide gene sequence, a functional region gene sequence and a connecting gene sequence, and the spacer gene sequence is arranged upstream of the functional region gene sequence, and the connecting gene sequence is arranged downstream of the functional region gene sequence, and the α-factor signal peptide gene sequence is arranged downstream of the connecting sequence, which can promote the functional region gene sequence of the galactosidase promoter to be connected to the spacer gene sequence and the α-factor signal peptide gene sequence respectively, thereby increasing the function of the functional region gene of the galactosidase promoter to improve the ability of the galactosidase promoter to initiate the expression of the dual promoter plasmid.

[0050] In some optional embodiments, the spacer gene sequence has a nucleotide sequence as shown in SEQ ID NO.2;

[0051] The α factor signal peptide gene sequence has a nucleotide sequence as shown in SEQ ID NO.3;

[0052] The connecting gene has a nucleotide sequence as shown in SEQ ID NO.4;

[0053] In these embodiments, the spacer gene sequence may have a nucleotide sequence as shown in SEQ ID NO.2, the α-factor signal peptide gene sequence may have a nucleotide sequence as shown in SEQ ID NO.3, and the linker gene may have a nucleotide sequence as shown in SEQ ID NO.4, which may further increase the function of the functional region gene of the β-galactosidase promoter to improve the ability of the β-galactosidase promoter to initiate dual-promoter plasmid expression.

[0054] In some optional embodiments, the β-galactosidase promoter has a nucleotide sequence as shown in SEQ ID NO.5;

[0055] In these embodiments, the β-galactosidase promoter may have a nucleotide sequence as shown in SEQ ID NO.5, and the specific sequence information of the β-galactosidase promoter may be further clarified to further improve the promoter ability of the dual-promoter plasmid, thereby promoting the expression of the pKLAC1 expression vector to increase the yield of foreign proteins heterologously expressed in Kluyveromyces lactis.

[0056] Figure 1 A schematic flow chart of a method for preparing a dual-promoter plasmid provided in an embodiment of the present application is exemplarily shown;

[0057] Figure 2 The schematic diagram of the principle of a method for preparing a dual-promoter plasmid provided in an embodiment of the present application is exemplarily shown;

[0058] Based on a general inventive concept, such as Figure 1 and Figure 2 As shown, the present application embodiment provides a method for preparing the dual promoter plasmid, the method comprising:

[0059] S1. Performing a first double restriction enzyme digestion on a plasmid containing a β-galactosidase promoter to obtain a promoter gene fragment;

[0060] S2. performing the first double enzyme digestion on the pKLAC1 expression vector to obtain a first vector digestion product;

[0061] S3. DNA ligating the promoter gene fragment and the vector digestion product to obtain a dual-promoter plasmid;

[0062] This method is a method for preparing the above-mentioned dual promoter plasmid. The specific composition information of the dual promoter plasmid can be referred to the above-mentioned embodiment. Since this method adopts part or all of the technical solutions of the above-mentioned embodiment, it at least has all the beneficial effects brought by the technical solutions of the above-mentioned embodiment, which will not be repeated here one by one.

[0063] It should be noted that this method connects the β-galactosidase promoter to the pKLAC1 expression vector by means of a first double-enzyme-cut DNA connection, thereby effectively combining each gene sequence of the β-galactosidase promoter into the pKLAC1 expression vector to form a dual-promoter plasmid.

[0064] It should be noted that T4 DNA ligase can be used for the DNA ligation.

[0065] In some optional embodiments, the enzymes used for the first double enzyme digestion include Hind III enzyme and Bgl II enzyme;

[0066] In these embodiments, the enzymes used for the first double enzyme digestion may include HindⅢ enzyme and BglⅡ enzyme. HindⅢ enzyme and BglⅡ enzyme can be used to cut out the galactosidase promoter in the plasmid containing the galactosidase promoter, and then cut out the same site on the pKLAC1 expression vector, and finally the galactosidase promoter and the pKLAC1 expression vector are fully connected by DNA connection, so as to obtain a dual-promoter plasmid.

[0067] Figure 3 The plasmid map of a recombinant expression strain of Kluyveromyces lactis provided in the examples of the present application is exemplarily shown;

[0068] Based on a general inventive concept, such as Figure 3 As shown, the embodiment of the present application provides a recombinant expression strain of Kluyveromyces lactis, and the recombinant expression strain has the dual promoter plasmid.

[0069] The recombinant expression strain is realized based on the above-mentioned dual promoter plasmid. The specific composition of the dual promoter plasmid can refer to the above-mentioned embodiment. Since the recombinant expression strain adopts part or all of the technical solutions of the above-mentioned embodiments, it has at least all the beneficial effects brought by the technical solutions of the above-mentioned embodiments, which will not be repeated here one by one.

[0070] Figure 4 A schematic flow chart of a method for constructing a recombinant expression strain of Kluyveromyces lactis provided in an embodiment of the present application is exemplarily shown;

[0071] Based on a general inventive concept, such as Figure 4As shown, the present application embodiment provides a method for constructing a recombinant expression strain of Kluyveromyces lactis, the method comprising:

[0072] S1. Perform a second double enzyme digestion on the plasmid containing the exogenous protein to obtain the exogenous protein gene fragment;

[0073] S2. Performing a second double enzyme digestion on the pKLAC1 vector to obtain a second vector digestion product;

[0074] S3. DNA ligating the exogenous protein gene fragment and the second vector digestion product to obtain a recombinant expression vector;

[0075] S4. using the method to transfer the β-galactosidase promoter into the recombinant expression vector to obtain a dual-promoter recombinant expression vector containing the β-galactosidase promoter;

[0076] S5. digesting the dual-promoter recombinant expression vector with enzymes to linearize the dual-promoter recombinant expression vector to obtain a linearized dual-promoter recombinant expression vector;

[0077] S6. mixing the linearized dual-promoter recombinant expression vector with Kluyveromyces lactis competent cells, and then performing electro-transformation to obtain a recombinant expression single strain;

[0078] S7. Inducing and amplifying the recombinant expression single strain using a culture medium with D-galactose as the sole carbon source to obtain a recombinant expression strain of Kluyveromyces lactis.

[0079] The method is a method for constructing the recombinant expression strain of the above-mentioned Kluyveromyces lactis. The specific composition information of the recombinant expression strain of Kluyveromyces lactis can be referred to the above-mentioned embodiment. Since the method adopts part or all of the technical solutions of the above-mentioned embodiment, it has at least all the beneficial effects brought by the technical solutions of the above-mentioned embodiment, which will not be repeated here one by one.

[0080] It should be noted that the first enzyme cutting and the second enzyme cutting do not refer to the order of enzyme cutting, but represent the operations of different enzyme cuttings.

[0081] In some embodiments, the expression gene of the exogenous protein has a nucleotide sequence as shown in SEQ ID NO.6;

[0082] The exogenous protein has an amino acid sequence as shown in SEQ ID NO.7;

[0083] In these embodiments, the expression gene of the exogenous protein can have a nucleotide sequence as shown in SEQ ID NO.6, and the exogenous protein can have an amino acid sequence as shown in SEQ ID NO.7, which can cause the exogenous protein to be a green fluorescent protein EGFP with green fluorescence, thereby facilitating the use of exogenous protein to reversely verify the effect of the dual promoter plasmid on expression improvement.

[0084] In some embodiments, the enzymes used for the second double enzyme digestion include AscⅠ enzyme and NotⅠ enzyme;

[0085] In these embodiments, the enzymes used for the second double digestion may include AscⅠ enzyme and NotⅠ enzyme.

[0086] In some embodiments, the enzyme used for the cleavage includes SacII enzyme;

[0087] In these embodiments, the enzyme used for enzyme cleavage may include SacII enzyme, and the SacII enzyme may be used to promote the linearization expression of the dual-promoter recombinant expression vector to obtain a linearized dual-promoter recombinant expression vector.

[0088] The present application is further described below in conjunction with specific examples. The experimental methods in the following examples that do not specify specific conditions are usually measured according to industry standards; if there are no corresponding industry standards, they are carried out according to common international standards, conventional conditions, or conditions recommended by the manufacturer.

[0089] Example 1

[0090] 1. Selection of experimental materials:

[0091] Calculated by mass fraction, the YCB solid culture medium includes: YNB with a mass concentration of 0.34%, glucose with a mass concentration of 1.0%, agar powder with a mass concentration of 1.5%, and acetamide with a mass concentration of 5.0 mmol / L.

[0092] In terms of mass fraction, the YPL liquid culture medium includes: 1.0% yeast powder, 2.0% peptone, and 2.0% glucose.

[0093] The YPG induction medium includes, by mass fraction, 1.0% yeast powder, 2.0% peptone, 1.5% D-galactose, and 1% α-lactose.

[0094] 2. Design of the amino acid sequence of the galactosidase promoter pScGAL7:

[0095] MTAEEFDFSSHSHRRYNPLTDSWILVSPHRAKRPWLGQQEAAYKPTAPLYDPKCYLCPGNKRATGNLNPRYESTYIFPNDYAAVRLDQPILPQNDSNEDNLKNRLLKVQSVRGNCFVICFSPNHNLTIPQMKQSDLVHIVNSWQALTDDLSREARENHKPFKYVQIFENKGTAMGCSNLHPHGQA WCLESIPSEVSQELKSFDKYKREHNTDLFADYVKLESREKSRVVVENESFIVVVPYWAIWPFETLVISKKKLASISQFNQMVKEDLASILKQLTIKYDNLFETSFPYSMGIHQAPLNATGDELSNSWFHMHFYPPLLRSATVRKFLVGFELLGEPQRDLTSEQAAAEKLRNLDGQIHYLQRL(SEQ IDNO.1).

[0096] Based on the designed pScGAL7 amino acid sequence, the nucleotide sequence of the pScGAL7 promoter was determined:

[0097]

[0098]

[0099] The sequence underlined with a single dash in the pScGAL7 nucleotide sequence is the spacer gene sequence: AAAAAACCCCGGATCGGACTACTAGCAGCTG (SEQ ID NO.2); the sequence underlined with a double dash in the pScGAL7 nucleotide sequence is the α factor signal peptide gene sequence: ATGAAATTCTCTACTATATTAGCCGCATCTACTGCTTTAATTTCCGTTGTTATGGCTGCTCCAGTTTCTACCGAAACTGACATCGACGATCTTCCAATATCGGTTCCAGAAGAAGCCTTGATTGGATTCATTGACTTAACCGGGGATGAAGTTTCCTTGTTGCCTGTTAATAACGGAACCCACACTGGTATTCTATTCTTAAACACCACCATCGCTGAAGCTGCTTTCGCTGACAAGGATGATCTCGAGAAAAGAGGCTGAAGCT (SEQ ID NO.3); the sequence underlined with a wavy dash in the pScGAL7 nucleotide sequence is the linker sequence: AGAAGAGCT (SEQ ID NO.4).

[0100] Also considering the verification problem of the dual-promoter plasmid, the expression gene of the foreign protein was designed as:

[0101] ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACTGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGCGAACTTCAAGATCCGCCACAACATCGAGGACGGCGGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAG(SEQ ID NO.6).

[0102] According to the expression gene of the above-mentioned exogenous protein, the corresponding amino acid sequence of the exogenous protein was designed: MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK (SEQ ID NO.7).

[0103] like Figure 4 As shown, a method for constructing a recombinant expression strain of Kluyveromyces lactis, the method comprising:

[0104] S1. Performing a second double enzyme digestion on the plasmid containing the foreign protein to obtain the foreign protein gene fragment, comprising the steps of:

[0105] (1) Prepare a 1.5 mL EP tube and add 50 μL of plasmid DNA containing exogenous protein, 36 μL of water, 10 μL of buffer, 2 μL of AscⅠ enzyme, and 2 μL of NotⅠ enzyme in sequence according to the requirements of the enzyme digestion system;

[0106] (2) Place the EP tube in a 37°C water bath and perform overnight enzyme digestion for 16 hours to obtain the double enzyme digestion product - the foreign protein gene fragment;

[0107] S2. Perform a second double enzyme digestion on the pKLAC1 vector to obtain a second vector digestion product; wherein the second digestion system includes: 50 μL of DNA template, 2.0 μL of AscⅠ enzyme, 2.0 μL of NotⅠ enzyme, 10 μL of Buffer, and add water to make up to 100 μL;

[0108] S3. The exogenous protein gene fragment and the second vector digestion product are subjected to DNA ligation at 16°C overnight using T4 DNA ligase to obtain a recombinant expression vector pKLAC-EGFP; wherein the DNA ligation system comprises: 5 μL of the exogenous protein gene fragment, 1 μL of the pKLAC fragment, 1 μL of T4 buffer, 0.5 μL of T4 DNA ligase, and water is added to make up to 10 μL;

[0109] S401. Performing a first double restriction digestion on a plasmid containing a β-galactosidase promoter to obtain a promoter gene fragment, comprising the steps of:

[0110] (1) Prepare a 1.5 mL EP tube and add 50 μL of DNA, 36 μL of water, 10 μL of buffer, 2 μL of Hind III enzyme, and 2 μL of Bgl II enzyme in sequence according to the enzyme digestion system;

[0111] (2) Place the EP tube in a 37°C water bath and perform overnight enzyme digestion for 16 hours to obtain a double enzyme digestion product - the promoter gene fragment;

[0112] S402. Perform the first double enzyme digestion on the recombinant expression vector pKLAC-EGFP to obtain a first vector digestion product; wherein the system used for the first digestion includes: 50 μL DNA, 2.0 μL HindⅢ, 2.0 μL BglⅡ, 10 μL Buffer, and add water to make up to 100 μL;

[0113] S403. The promoter gene fragment and the vector digestion product are subjected to DNA ligation at 16° C. overnight using T4 DNA ligase to obtain a dual-promoter recombinant expression vector pKLAC1-pScGAL7-EGFP; wherein the DNA ligation system comprises: 5 μL of pScGAL7 gene fragment, 1 μL of pKLAC-EGFP fragment, 1 μL of T4 buffer, 0.5 μL of T4 DNA ligase, and water is added to make up to 10 μL;

[0114] S5. using SacII enzyme to digest the recombinant expression vector pKLAC-EGFP and the dual-promoter recombinant expression vector pKLAC1-pScGAL7-EGFP to linearize the recombinant expression vector pKLAC-EGFP and the dual-promoter recombinant expression vector to obtain a linearized recombinant expression vector and a dual-promoter recombinant expression vector;

[0115] S6. 10 μL of the linearized recombinant expression vector or the dual-promoter recombinant expression vector were mixed with 90 μL of fresh Kluyveromyces lactis competent cells, and then electroporated to obtain a recombinant expression single strain; comprising the steps of:

[0116] 10 μL of linearized recombinant expression vector or dual-promoter recombinant expression vector was mixed with 90 μL of fresh Kluyveromyces lactis GG799 competent cells, and placed in an ice bath for 5 min. The linearized product and competent cell mixture in the ice bath was then transferred to an ice-cooled electroporation cup for electroporation (the electroporation parameters included: the electroporation voltage was 1550 V, the electroporation resistance was 200 Ω, and the electroporation temperature was 25 μF). Then, 1 mL of preheated 28°C electroporation solution was quickly added to the electroporation cup. 1.5 mL of YPD medium, and then transferred to a 1.5 mL sterile centrifuge tube, and placed in an incubator at 28°C for 2 h; then 100 μL of the bacterial solution was spread on a YCB plate containing 5 mm p-acetamide at a final concentration, and placed in an incubator at 28°C for 3 to 5 days. After a single colony grew out, a recombinant expression strain of Kluyveromyces lactis containing green fluorescent protein (EGFP) and a recombinant expression strain of Kluyveromyces lactis containing a β-galactosidase promoter (pScGAL7) and green fluorescent protein (EGFP) were obtained respectively;

[0117] S7. Inducing and amplifying the recombinant expression single strain to obtain a recombinant expression strain of Kluyveromyces lactis; comprising the steps of:

[0118] Each recombinant expression strain in step S6 was inoculated into 5 mL of YPD medium, and cultured overnight at a constant temperature of 28° C. with shaking to obtain a seed solution;

[0119] The seed solution was inoculated into a shake flask containing 25 mL of YPD medium and cultured overnight;

[0120] Collect the bacteria and transfer them to 25 mL of YPG medium for further culture;

[0121] D-galactose was added at a mass concentration of 2.5% every 24 hours until the fermentation was stopped at 72 hours;

[0122] The fermentation supernatant was taken and detected by SDS-PAGE.

[0123] Related experiments and effect data:

[0124] 1. Detect the recombinant expression vector after single enzyme digestion and the dual promoter recombinant expression vector. The results are as follows: Figure 5 As shown, this indicates that the recombinant expression vector pKLAC-EGFP and the dual promoter recombinant expression vector pKLAC1-pScGAL7-EGFP were successfully constructed.

[0125] 2. The recombinant expression vector pKLAC-EGFP and the dual promoter recombinant expression vector pKLAC1-pScGAL7-EGFP were digested with four enzymes and tested. The results were as follows: Figure 6As shown, this indicates that the four-enzyme digestion of the recombinant expression vector pKLAC-EGFP can obtain two products, pKLAC and EGFP; and the four-enzyme digestion of the dual-promoter recombinant expression vector pKLAC1-pScGAL7-EGFP can obtain three products, pKLAC, pScGAL7 and EGFP.

[0126] 3. The proteins expressed by the recombinant expression vector pKLAC-EGFP and the dual promoter recombinant expression vector pKLAC1-pScGAL7-EGFP after electroporation were detected. The results are as follows: Figure 7 As shown, the corresponding concentration was then detected by Bradford. The concentration of the fermentation supernatant containing the recombinant expression vector pKLAC-EGFP was 0.35 mg / mL, while the concentration of the fermentation supernatant containing the dual promoter recombinant expression vector pKLAC1-pScGAL7-EGFP was 1.91 mg / mL, which indicates that the dual promoter recombinant expression vector pKLAC1-pScGAL7-EGFP can increase the yield of the corresponding protein by about 5.5 times.

[0127] In summary, a dual-promoter plasmid provided in the embodiments of the present application can greatly increase the expression amount of exogenous protein in Kluyveromyces lactis by adding a β-galactosidase promoter to the pKLAC1 expression vector. For example, compared with the original expression vector pKLAC1, the dual-promoter recombinant expression vector pKLAC1-pScGAL7 can increase the production of exogenous protein (such as green fluorescent protein / EGFP) to 5.5 times, which shows that exogenous protein has the advantage of efficient expression in Kluyveromyces lactis engineered bacteria.

[0128] In addition, the recombinant expression strain of Kluyveromyces lactis provided in the examples of the present application can lay a foundation for subsequent industrial production.

[0129] The above is only a specific implementation of the present application, so that those skilled in the art can understand or implement the present application. It will be apparent to those skilled in the art that various modifications to these embodiments are possible, and the general principles defined in the present application can be implemented in other embodiments without departing from the spirit or scope of the present application. Therefore, the present application will not be limited to these embodiments shown in the present application, but will conform to the widest scope consistent with the principles and novel features applied for by the present application.

Claims

1. A dual promoter plasmid, characterized in that: The dual promoter plasmid comprises: pKLAC1 expression vector and a β-galactosidase promoter connected in series on the pKLAC1 expression vector, wherein the protein expressed by the β-galactosidase promoter has an amino acid sequence as shown in SEQ ID NO.

1.

2. The dual promoter plasmid according to claim 1, characterized in that The galactosidase promoter comprises an interval gene sequence, an α-factor signal peptide gene sequence, a functional region gene sequence and a connecting gene sequence; the interval gene sequence is arranged upstream of the functional region gene sequence, the connecting gene sequence is arranged downstream of the functional region gene sequence, and the α-factor signal peptide gene sequence is arranged downstream of the connecting sequence.

3. The dual promoter plasmid according to claim 2, characterized in that The spacer gene sequence has a nucleotide sequence as shown in SEQ ID NO.2; The α factor signal peptide gene sequence has a nucleotide sequence as shown in SEQ ID NO.3; The connecting gene has a nucleotide sequence as shown in SEQ ID NO.

4.

4. The dual promoter plasmid according to claim 3, characterized in that The β-galactosidase promoter has a nucleotide sequence as shown in SEQ ID NO.

5.

5. A method for preparing the dual promoter plasmid according to any one of claims 1 to 4, characterized in that: The method comprises: The plasmid containing the β-galactosidase promoter is subjected to a first double restriction enzyme digestion to obtain a promoter gene fragment; Performing the first double enzyme digestion on the pKLAC1 expression vector to obtain a first vector enzyme digestion product; The promoter gene fragment and the vector enzyme-cut product are connected by DNA to obtain a double-promoter plasmid.

6. The method according to claim 5, characterized in that The enzymes used for the first double enzyme digestion include HindⅢ enzyme and BglⅡ enzyme.

7. A recombinant expression strain of Kluyveromyces lactis, characterized in that: The recombinant expression strain has the dual promoter plasmid according to any one of claims 1 to 4.

8. A method for constructing a recombinant expression strain of Kluyveromyces lactis according to claim 7, characterized in that: The method comprises: Performing a second double enzyme digestion on the plasmid containing the foreign protein to obtain the foreign protein gene fragment; Perform a second double enzyme digestion on the pKLAC1 vector to obtain a second vector digestion product; Performing DNA ligation on the exogenous protein gene fragment and the second vector digestion product to obtain a recombinant expression vector; Using the method according to claim 5 or 6 to transfer the β-galactosidase promoter into the recombinant expression vector to obtain a dual-promoter recombinant expression vector containing the β-galactosidase promoter; Cutting the dual-promoter recombinant expression vector with enzymes to linearize the dual-promoter recombinant expression vector, thereby obtaining a linearized dual-promoter recombinant expression vector; The linearized dual-promoter recombinant expression vector is mixed with Kluyveromyces lactis competent cells, and then electro-transformed to obtain a recombinant expression single strain; The recombinant expression single strain is induced and amplified using a culture medium with D-galactose as the sole carbon source to obtain a recombinant expression strain of Kluyveromyces lactis.

9. The method according to claim 8, characterized in that The expression gene of the exogenous protein has a nucleotide sequence as shown in SEQ ID NO.6; The exogenous protein has an amino acid sequence as shown in SEQ ID NO.

7.

10. The method according to claim 8, characterized in that The enzymes used in the second double enzyme digestion include AscⅠ enzyme and NotⅠ enzyme; The enzyme used for the enzyme cleavage includes SacII enzyme.